Cargos activos de Patrik Ernfors
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Glionova AB
 Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Director/Miembro de la Junta | 01/01/2014 | - |
| Fundador | 01/01/2014 | - |
Historial de carrera de Patrik Ernfors
Antiguos cargos conocidos de Patrik Ernfors.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Global Genomics AB
 Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Global Genomics AB used to discovers disease genes, drug targets and disease-associated biomarkers. It was also developing and out-licenses proprietary tools in functional genomics that provide insight into healthy, diseased or drug-treated cells. The company was founded by Patrik Ernfors & Sten Linnarsson in September, 2000 and was located in Stockholm, Sweden. | Director Técnico/Científico/I+D | 01/09/2000 | - |
Estadísticas
Internacional
| Suecia | 3 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
| Founder | 1 |
Sectorial
| Commercial Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Global Genomics AB
Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Global Genomics AB used to discovers disease genes, drug targets and disease-associated biomarkers. It was also developing and out-licenses proprietary tools in functional genomics that provide insight into healthy, diseased or drug-treated cells. The company was founded by Patrik Ernfors & Sten Linnarsson in September, 2000 and was located in Stockholm, Sweden. | Commercial Services |
Glionova AB
Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Patrik Ernfors
- Experiencia
